It was reported that a (b)(6) year old male with a long-term picc was admitted to a hospital for wound debridement and biopsy for a non-healing abdominal wound/enterocutaneous fistula.
The patient developed a fever five days post-op.
Blood culture and line tip culture tested positive for serratia marcescens.
Information regarding a specific bd device was not provided.
Out of an abundance of caution and in the interest of public health, bd voluntarily recalled certain lots of bd posiflush¿ heparin lock flush and bd¿ pre-filled normal saline flush syringes due to a potential for contamination with serratia marcescens bacterium.
Bd was notified by the u.
S.
Food and drug administration (fda) and (b)(6) about a potential epidemiological link between catheter related blood stream infections and the s.
Marcescens bacterium.
Specifically, the fda and (b)(6) identified a potential connection between reports of infection in a small number of patients caused by s.
Marcescens across multiple states.
(b)(6)'s initial investigation found that affected patients had received treatment using certain bd flush products.
To date, there is no evidence of bd flush product testing positive for this bacterium.
Investigations are ongoing by bd, fda, and (b)(6).
|